Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026)

Sight Sciences' (SGHT) quarterly Net Income towards Common Stockholders came in at -$13.0 million in Q1 2026, up 8.29% year-on-year from -$12.0 million in Q1 2025, and down 211.87% quarter-over-quarter from -$4.2 million in Q4 2025.

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Sight Sciences' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.0 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 8.29% year-over-year to -$13.0 million in Q1 2026; TTM through Mar 2026 was -$37.3 million, a 24.58% increase from a year earlier, with the FY2025 full-year figure at -$38.4 million, up 25.4% from the prior year.
  • Net Income towards Common Stockholders declined to -$13.0 million in Q1 2026 per SGHT's latest filing, from -$4.2 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at -$4.2 million in Q4 2025 and bottomed at -$23.8 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$13.0 million (2023), against an average of -$14.4 million.
  • Across the five-year window, Net Income towards Common Stockholders slumped 90.06% in 2022 and soared 64.87% in 2025, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$16.9 million in 2022, then soared by 36.77% to -$10.7 million in 2023, then fell by 10.8% to -$11.8 million in 2024, then surged by 64.87% to -$4.2 million in 2025, then sank by 211.87% to -$13.0 million in 2026.
  • Per Business Quant, the three latest SGHT Net Income towards Common Stockholders figures stand at -$13.0 million (Q1 2026), -$4.2 million (Q4 2025), and -$8.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Sight Sciences 278.35 Mn 193.38 Mn 16.98 Mn -12.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 -4.16 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn
Jun 30, 2021 -17.62 Mn